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Background. In adults, it has been shown that obesity is associated with gastroesophageal reﬂux disease (GERD) and GERD-related
complications. There are sparse pediatric data demonstrating associations between childhood overweight and GERD. Objective.
To investigate the association between childhood overweight and RE. Methods. We performed a retrospective chart review of 230
children (M:F = 114 :116) who underwent esophagogastroduodenoscopy (EGD) with biopsies between January 2000 and April
2006. Patient demographics, weight, height, clinical indications for the procedure, the prevalence of BMI classiﬁcation groups,
the prevalence of RE and usage of anti-reﬂux medications were reviewed. For these analyses, the overweight group was deﬁned
to include subjects with BMI ≥ 85th percentile. The normal weight group was deﬁned to include subjects with BMI 5th to 85th
percentile. Results. Among the 230 subjects, 67 (29.1%) had BMI percentiles above the 85th percentile for age and gender. The
prevalence of RE in the overweight group did not diﬀer signiﬁcantly from that in the normal weight group (23.9% versus 24.5%,
resp.).Overweightsubjectstakinganti-reﬂuxmedicationsclearlydemonstratedahigherprevalenceofbiopsy-provenREcompared
to overweight subjects not taking anti-reﬂux medications (34.1% versus 7.7%, P = .009). Conclusions. There was no signiﬁcant
diﬀerence in the prevalence of biopsy-proven RE in the overweight group compared to the normal weight group. However, the
prevalence of RE was signiﬁcantly higher in overweight subjects on anti-reﬂux medications compared to overweight subjects
not taking anti-reﬂux medications. This ﬁnding emphasizes the importance of early recognition and treatment of GERD for the
overweight pediatric patients with symptoms in conjunction with weight loss program for this population to reduce long-term
morbidities associated with GERD.
1.Introduction
Obesity is now regarded as a disease of epidemic proportions
in the United States. Data from the National Health and
Nutrition Examination Survey (NHANES) demonstrate that
the prevalence of overweight in children and adolescents has
been rising at a staggering rate during the last several decades
[1,2].The2003-to-2004surveyindicatedthatapproximately
17percentofchildrenandadolescentsaged2to19yearswere
overweight. This represents a dramatic increase from the
NHANES III (1988 to 1994) overweight ﬁgure of 11 percent.
The ﬁnding that overweight children are at risk of becoming
overweight adults [3] is especially concerning given that
overweightadultshaveelevatedrisksofdevelopingmetabolic2 Journal of Obesity
and cardiac disorders [4]. In particular, abdominal obesity
has been linked to serious morbidities, such as diabetes
mellitus [5], heart disease [6], and certain cancers [7]. The
health implications of childhood overweight have served as
an impetus for major public health concern in the United
States.
In adults, obesity and overweight are independent risk
factors for gastroesophageal reﬂux disease (GERD) and
endoscopy-proven esophageal erosions [8]. Adults with
chronic GERD are at risk of developing associated compli-
cations, such as erosive esophagitis [9], Barrett’s esophagus
[10] and adenocarcinoma of the esophagus [11]. There is
a growing body of evidence that illustrates the association
between increasing body mass index (BMI) and GERD.
Cross-sectional studies and meta-analyses have conﬁrmed
this association in adult subjects [12, 13]. A few studies
haveestablishedacleardose-dependentrelationshipbetween
increasing BMI and GERD symptoms [8, 14, 15]. Similar
data in the pediatric literature are sparse. A study published
byStørdaletal.in2006demonstratedanassociationbetween
increasing BMI and GERD in children aged 7 to 16 years,
as reported by symptoms or pH monitoring abnormalities
[16]. A recent retrospective review by Elitsur et al. did not
reveal a greater prevalence of RE in children who were
overweight or obese compared to those with normal weight
[17]. In this study, we evaluated the association between RE
and overweight in children, instead of clinical symptoms
or endoscopic ﬁndings consistent with GERD. A study
published by Zentilin et al. in 2005 showed that histology
couldprovideusefulandobjectiveadditionaldatainpatients
with nonerosive reﬂux disease [18]. Furthermore, Lombardi
et al. suggested that esophageal biopsies are very important
aidsinthediagnosisofesophagitissinceclinicalsymptomsof
GERD or endoscopic visual ﬁndings do not always correlate
with histologic abnormalities [19].
2. Patientsand Methods
2.1. Patients. Ar e t r o s p e c t i v ec h a r tr e v i e wo fa l lp a t i e n t s
between the ages of 2 and 20 years who underwent upper
endoscopies with biopsies at New York Weill Cornell Medical
CenterbetweenJanuary2000andApril2006wascarriedout.
The following exclusion criteria were used: (1) procedures
with absence of esophageal biopsies, (2) repeated upper
endoscopies on already-included subjects, (3) unavailability
of all required information (e.g., anthropometric data at the
time of procedure), and (4) subjects with BMI <5% ile.
Charts were reviewed for the following data: age, gender,
weight, height, indication for the procedure, presence of RE,
andusageofantireﬂuxmedications(protonpumpinhibitors
or H2 receptor antagonists) at the time of the procedure for
at least 10 days. Weight and height were used to calculate
BMI percentiles on 2000 Centers for Disease Control sex-
speciﬁc BMI-for-age growth charts, which deﬁne BMI ≥
95th percentile to be overweight and BMI ≥ 85th percentile
and < 95th percentile to be at risk for overweight [20].
BMI ≥ 85th percentile was classiﬁed as overweight for the
purpose of this study. Age- and gender-speciﬁc z-scores for
weightandBMIwerecalculated.Twohundredthirtypatients
were included in this study, and detailed characterization
and analysis of these subjects (M : F = 114 : 116) were
conducted. The mean age of the study sample was 11.3 years.
The indication for the procedures in order of prevalence was
as follows: recurrent abdominal pain (n = 151, 65.6%),
clinical GERD symptoms (n = 51, 22.2%), weight loss
(n = 18, 7.8%), conditions such as upper GI bleeding
or IBD surveillance (n = 8, 3.5%), and suspected allergic
gastrointestinal disorders (n = 2, 0.9%).
2.2. Endoscopy and Biopsy. All endoscopies were performed
using video gastroscopes (Pentax, Japan) EG1840, EG2430,
or EG2731. Biopsy specimens were taken from the gastric
antrum and distal esophagus during the procedure. The
specimens were immediately ﬁxed in 10% buﬀered formalin
s o l u t i o n ,e m b e d d e di np a r a ﬃn, cut at 4–6 microns thick,
and stained with hematoxylin-eosin (H&E) for histologic
evaluation. A diagnosis of RE was based on histologic
ﬁndings of basal cell hyperplasia with eosinophilic exocytosis
(in the absence of such ﬁndings in the upper esophagus).
All esophageal biopsy slides were reevaluated by a single
pathologist, for grading of the esophagitis using a modiﬁ-
cation of the scale suggested by Zentilin et al. [18]. Biopsy
specimens were graded on a 4-point scale; 0/3 = normal, no
basal cell hyperplasia, minimal (less than 3 eosinophils/high
power ﬁeld (HPF) exocytosis; 1/3 = mild (up to 1/3 of
epithelial thickness) basal cell hyperplasia, minimal to mild
(between 2 and 8 eosinophils/HPF) exocytosis (mild active
esophagitis); 2/3 = moderate (from 1/3 to 2/3 of epithe-
lial thickness) basal cell hyperplasia, moderate (between
10 and 15 eosinophils/HPF) exocytosis (moderate active
esophagitis); 3/3 = marked (2/3 to full-thickness) basal cell
hyperplasia, marked (over 20 eosinophils/HPF) exocytosis
(severe active esophagitis) [21].
The study was approved by the Institutional Review
Board of Weill Medical College of Cornell University.
3. Statistics
Comparisons between groups were performed using the
uncertainty coeﬃcient. P-value of <.05 was accepted as
indicating statistical signiﬁcance. All statistical analyses were
performed using commercially available computer software
(SPSS for Windows).
4. Results
A total of 230 subjects were included in the study (Table 1).
The mean age was 11.3 years (s.d. = 4.7 years), and 114
(49.6%) were male. Forty-two percent of the subjects were
between 2 and 10 years of age and 58% from 11 to 20
years. A total of 163 subjects were classiﬁed as normal BMI
(70.9%), 29 as at risk for overweight (12.6%), and 38 as
overweight (16.5%); therefore 67 (29.1%) were deﬁned as
overweight. Symptoms of clinical GERD were the indication
for endoscopy in 22.2% of subjects. Histologic evidence of
RE was seen in 24.3% of subjects. The majority of subjectsJournal of Obesity 3
Table 1: Characteristics of study population.
Characteristics Number of patients
Study population 230
Age
2–10 years 97 (42.2%)
11–19 years 133 (57.8%)
Gender
Female 116 (50.4%)
Male 114 (49.6%)
Indications
Abdominal pain 151 (65.7%)
Clinical GERD symptoms 51 (22.2%)
Weight loss 18 (7.8%)
Other (UGI bleeding, Crohn’s disease) 8 (3.5%)
Rule out allergy 2 (0.8%)
BMI
Normal BMI (5%–85%ile) 163 (70.9%)
At risk for overweight (85–95%ile) 29 (12.6%)
Overweight (>95%ile) 38 (16.5%)
RE
No 174 (75.7%)
Yes 56 (24.3%)
Antireﬂux medication use
No 101 (43.9%)
Yes 129 (56.1%)
Table 2: Comparison between BMI group and presence of RE.
Normal BMI Overweight P-value
Presence of RE
No 123 51 .916
Yes 40 (24.5%) 16 (23.9%)
Table 3: Comparison of RE based on antireﬂuxmedication useand
BMI group.
RE P-value
No Yes
Medication use in normal weight group
No 58 17 (22.7%) .607
Yes 65 23 (26.1%)
Medication use in overweight group
No 24 2 (7.7%) .009
Yes 27 14 (34.1%)
in this study (129, 56.1%) were on antireﬂux therapy at the
time of endoscopy.
As evident in Table 2, the prevalence of RE in the
overweight group did not diﬀer signiﬁcantly from that
in the normal weight group (23.9% versus 24.5%, resp.).
Overweight subjects taking antireﬂux medications demon-
strated a higher prevalence of biopsy-proven RE compared
to overweight subjects not taking antireﬂux medications
(34.1% versus 7.7%, P = .009), as seen in Table 3.
Table 4: Prevalence of RE and overweight based on age group.
2–10 years 11–19 years P-value
RE
No 66 108 .022
Yes 31 (32.0%) 25 (18.8%)
Overweight
No 60 103 .010
Yes 37 (38.1%) 30 (22.6%)
A secondary analysis based on age (Table 4) comparing
prepubertal subjects (2 to 10 years) to older subjects (11
to 19 years) showed that the younger subjects had a higher
prevalence of both RE (32.0% versus 18.8%, P = .022) and
overweight (38.1% versus 22.6%, P = .010).
5. Discussion
Our study does not suggest that there is a greater prevalence
of RE among overweight children. There was no dose-
responserelationshipbetweenGERDsymptomsandincreas-
ing BMI category. However the analyses did reveal that the
overweight subjects on antireﬂux therapy had a signiﬁcantly
higher prevalence of biopsy-proven RE as compared to
the overweight subjects not taking antireﬂux medications.
This ﬁnding may suggest that higher-BMI patients with
symptomatology necessitating antireﬂux therapy should be
targeted for aggressive therapy, and weight loss should be
advocated to mediate this eﬀect.
Numerous adult studies have demonstrated a positive
correlation between obesity and GERD by using clinical
gastroesophageal symptoms and esophageal pH monitoring
in relation to obesity [14, 15, 22–27]. The ﬁnding of
endoscopically detected RE has been a useful endpoint in
studies investigating the relationship between GERD and
obesity [8, 22, 23]. As mentioned earlier, our study used the
prevalence of RE instead of symptomatology or endoscopic
appearance consistent with GERD.
Our study did not support the positive relationship
between BMI and GERD in children and adolescents, it
is consistent with the ﬁndings published by Elitsur etal.
[17]. Several theories may help to explain the lack of direct
correlation between increasing BMI and RE in our pediatric
sample. The cumulative length of time of esophageal acid
exposure may be greater in adults with long-standing over-
weight, as compared to in children, leading to more clinically
relevant GERD symptoms and greater mucosal damage
and esophagitis. Since overweight subjects are at higher
risk of developing both acid and nonacid reﬂux diseases
[28], the use of multichannel intraluminal impedance (MII)
monitoring may be useful to investigate this relationship in
future prospective trials.
High percentage of our patients (56.1%) was using
antireﬂux medications at the time of endoscopy and it is
conceivable that we could have underestimated the true
prevalence of RE in our population, both the overweight
and normal weight groups. We did not exclude patients4 Journal of Obesity
with confounding factors that are known to increase the
risk of developing GERD, such as those with neuromus-
cular disorders, Down syndrome, and chronic pulmonary
conditions. We did not perform pH probe study or MII
monitoring to detect acid reﬂux as well as nonacid reﬂux
since this was a retrospective study. Furthermore, given the
reliability of waist circumference as a marker of visceral
adiposity, it may have been more favorable to utilize this
measure to investigate the relationship between overweight
and GERD.
In summary, our study showed no signiﬁcant diﬀerence
in the prevalence of biopsy-proven RE in the overweight
group compared to the normal weight group in children.
However, future prospective trials utilizing tools to measure
acid as well as non-acid reﬂux (such as MII) may be useful to
better understand this relationship.
References
[ 1 ]C .L .O g d e n ,M .D .C a r r o l l ,L .R .C u r t i n ,M .A .M c D o w e l l ,
C. J. Tabak, and K. M. Flegal, “Prevalence of overweight
and obesity in the United States, 1999–2004,” Journal of the
American Medical Association, vol. 295, no. 13, pp. 1549–1555,
2006.
[2] C. L. Ogden, K. M. Flegal, M. D. Carroll, and C. L. Johnson,
“Prevalence and trends in overweight among US children
and adolescents, 1999-2000,” Journal of the American Medical
Association, vol. 288, no. 14, pp. 1728–1732, 2002.
[3] R.C.W hitaker ,J .A.W right,M.S.P epe,K.D .Seidel,andW .H.
Dietz,“Predictingobesityinyoungadulthoodfromchildhood
and parental obesity,” New England Journal of Medicine, vol.
337, no. 13, pp. 869–873, 1997.
[4] A. Must, J. Spadano, E. H. Coakley, A. E. Field, G. Colditz, and
W. H. Dietz, “The disease burden associated with overweight
and obesity,” Journal of the American Medical Association, vol.
282, no. 16, pp. 1523–1529, 1999.
[5] E. J. Boyko, W. Y. Fujimoto, D. L. Leonetti, and L. Newell-
Morris, “Visceral adiposity and risk of type 2 diabetes: a
prospective study among Japanese Americans,” Diabetes Care,
vol. 23, no. 4, pp. 465–471, 2000.
[6] M. Dalton, A. J. Cameron, P. Z. Zimmet, et al., “Waist
circumference, waist-hip ratio and body mass index and
their correlation with cardiovascular disease risk factors in
Australian adults,” Journal of Internal Medicine, vol. 254, no.
6, pp. 555–563, 2003.
[7] E. Giovannucci, “Obesity, gender, and colon cancer,” Gut, vol.
51, no. 2, p. 147, 2002.
[8] H. B. El-Serag, D. Y. Graham, J. A. Satia, and L. Rabeneck,
“Obesity is an independent risk factor for GERD symptoms
and erosive esophagitis,” American Journal of Gastroenterology,
vol. 100, no. 6, pp. 1243–1250, 2005.
[9] H. B. El-Serag and J. F. Johanson, “Risk factors for the severity
of erosive esophagitis in Helicobacter pylori-negative patients
with gastroesophageal reﬂux disease,” Scandinavian Journal of
Gastroenterology, vol. 37, no. 8, pp. 899–904, 2002.
[10] B. J. Reid and W. M. Weinstein, “Barrett’s esophagus and
adenocarcinoma,” Annual Review of Medicine, vol. 38, pp.
477–492, 1987.
[11] J. Lagergren, R. Bergstr¨ om, A. Lindgren, and O. Nyr´ en,
“Symptomatic gastroesophageal reﬂux as a risk factor for
esophageal adenocarcinoma,” New England Journal of Medi-
cine, vol. 340, no. 11, pp. 825–831, 1999.
[ 1 2 ]H .H a m p e l ,N .S .A b r a h a m ,a n dH .B .E l - S e r a g ,“ M e t a -
analysis: obesity and the risk for gastroesophageal reﬂux
diseaseanditscomplications,”AnnalsofInternalMedicine,vol.
143, no. 3, pp. 199–211, 2005.
[13] D. A. Corley and A. Kubo, “Body mass index and gas-
troesophageal reﬂux disease: a systematic review and meta-
analysis,” American Journal of Gastroenterology, vol. 101, no.
11, pp. 2619–2628, 2006.
[ 1 4 ]G .R .L o c k eI I I ,N .J .T a l l e y ,S .L .F e t t ,A .R .Z i n s m e i s t e r ,a n d
L. J. Melton III, “Risk factors associated with symptoms of
gastroesophageal reﬂux,” American Journal of Medicine, vol.
106, no. 6, pp. 642–649, 1999.
[15] L. Murray, B. Johnston, A. Lane, et al., “Relationship between
body mass and gastro-oesophageal reﬂux symptoms: the
BristolHelicobacter Project,” International Journal of Epidemi-
ology, vol. 32, no. 4, pp. 645–650, 2003.
[16] K.Størdal,G.B.Johannesdottir,B.S.Bentsen,K.C.L.Carlsen,
and L. Sandvik, “Asthma and overweight are associated with
symptoms of gastro-oesophageal reﬂux,” Acta Paediatrica, vol.
95, no. 10, pp. 1197–1201, 2006.
[17] Y. Elitsur, Y. Dementieva, R. Elitsur, and M. Rewalt, “Obesity
is not a risk factor in children with reﬂux esophagitis: a
retrospective analysis of 738 children,” Metabolic Syndrome
and Related Disorders, vol. 7, no. 3, pp. 211–214, 2009.
[18] P. Zentilin, V. Salvarino, L. Mastracci, et al., “Reassessment
of the diagnostic value of histology in patients with GERD,
using multiple biopsy sites and an appropriate control group,”
American Journal of Gastroenterology, vol. 100, no. 10, pp.
2299–2306, 2005.
[19] G. Lombardi, G. de’ Angelis, V. Rutigliano, et al., “Reﬂux
oesophagitis in children; the role of endoscopy. A multicentric
Italian survey,” Digestive and Liver Disease,v o l .3 9 ,n o .9 ,p p .
864–871, 2007.
[20] R. J. Kuczmarski, C. L. Ogden, L. M. Grummer-Strawn, et al.,
“CDC growth charts: United States,” Advance Data, no. 314,
pp. 1–27, 2000.
[21] A. Moon, A. Solomon, D. Beneck, and S. Cunningham-
Rundles, “Positive association between helicobacter pylori
and gastroesophageal reﬂux disease in children,” Journal of
Pediatric Gastroenterology and Nutrition,v o l .4 9 ,n o .3 ,p p .
283–288, 2009.
[22] B. L. Fisher, A. Pennathur, J. L. Mutnick, and A. G. Little,
“Obesity correlates with gastroesophageal reﬂux,” Digestive
Diseases and Sciences, vol. 44, no. 11, pp. 2290–2294, 1999.
[23] S. A. Wajed, C. G. Streets, C. G. Bremner, and T. R. DeMeester,
“Elevated body mass disrupts the barrier to gastroesophageal
reﬂux,” Archives of Surgery, vol. 136, no. 9, pp. 1014–1019,
2001.
[24] H. B. El-Serag, G. A. Ergun, J. Pandolﬁno, S. Fitzgerald, T.
Tran, and J. R. Kramer, “Obesity increases oesophageal acid
exposure,” Gut, vol. 56, no. 6, pp. 749–755, 2007.
[25] B. C. Jacobson, S. C. Somers, C. S. Fuchs, C. P. Kelly, and
C. A. Camargo Jr., “Body-mass index and symptoms of
gastroesophageal reﬂux in women,” New England Journal of
Medicine, vol. 354, no. 22, pp. 2340–2348, 2006.
[26] S. Nandurkar, G. R. Locke III, S. Fett, A. R. Zinsmeister, A. J.
Cameron, and N. J. Talley, “Relationship between body mass
index, diet, exercise and gastro-oesophageal reﬂux symptoms
in a community,” Alimentary Pharmacology and Therapeutics,
vol. 20, no. 5, pp. 497–505, 2004.Journal of Obesity 5
[27] M. Nilsson, R. Johnsen, W. Ye, K. Hveem, and J. Lagergren,
“Obesity and estrogen as risk factors for gastroesophageal
reﬂux symptoms,” JournaloftheAmericanMedicalAssociation,
vol. 290, no. 1, pp. 66–72, 2003.
[ 2 8 ]J .M .E .S c h n e i d e r ,B .L .D .M .B r u c h e r ,M .K u p e r ,e t a l . ,
“Multichannel intrluminal impedance measurement of gas-
troesophagealreﬂuxinpatientswithdiﬀerentstagesofmorbid
obesity,” Obesity Surgery, vol. 19, pp. 1522–1529, 2009.